{"id":40059,"date":"2026-10-27T08:00:00","date_gmt":"2026-10-27T07:00:00","guid":{"rendered":"https:\/\/ggba.swiss\/?p=40059"},"modified":"2026-10-20T11:08:00","modified_gmt":"2026-10-20T09:08:00","slug":"de-lepfl-au-nasdaq-comment-lia-transforme-le-diagnostic-du-cancer-entretien-avec-jurgi-camblong","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/de-lepfl-au-nasdaq-comment-lia-transforme-le-diagnostic-du-cancer-entretien-avec-jurgi-camblong\/","title":{"rendered":"De l\u2019EPFL au NASDAQ : comment l\u2019IA transforme le diagnostic du cancer (Entretien avec Jurgi Camblong)"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Biologiste mol\u00e9culaire de formation, titulaire d\u2019un doctorat de l\u2019Universit\u00e9 de Gen\u00e8ve et d\u2019un postdoctorat \u00e0 Oxford, Jurgi Camblong cofonde SOPHiA GENETICS en 2011 avec une conviction claire : \u00e0 mesure que le s\u00e9quen\u00e7age de l\u2019ADN deviendrait plus rapide et moins co\u00fbteux, les h\u00f4pitaux auraient besoin d\u2019un moyen d\u2019interpr\u00e9ter ces donn\u00e9es. Quinze ans plus tard, un millier d\u2019h\u00f4pitaux dans 70 pays utilisent la plateforme d\u2019IA de l\u2019entreprise, plus de deux millions de profils g\u00e9nomiques ont \u00e9t\u00e9 analys\u00e9s, et en 2021, SOPHiA est devenue l\u2019une des rares entreprises technologiques suisses \u00e0 entrer au NASDAQ.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La conversation retrace ce parcours depuis ses d\u00e9buts, lorsque Camblong a entam\u00e9 un Executive MBA le jour m\u00eame o\u00f9 il est devenu CEO, et a pass\u00e9 des ann\u00e9es \u00e0 frapper aux portes des h\u00f4pitaux pour comprendre ce dont les m\u00e9decins avaient r\u00e9ellement besoin. Il explique pourquoi la vente est le v\u00e9ritable moteur de l\u2019innovation, pourquoi les start-up devraient mettre leur produit sur le march\u00e9 rapidement plut\u00f4t que d\u2019attendre la perfection, et pourquoi la Suisse a offert \u00e0 son entreprise un avantage concurrentiel bien r\u00e9el : l\u2019acc\u00e8s \u00e0 des talents rares pour un tiers du co\u00fbt de la Silicon Valley, une qualit\u00e9 de vie qui retient ces talents, et des autorit\u00e9s locales capables de faire d\u00e9livrer un permis de travail en une semaine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Il partage \u00e9galement ses conseils \u00e0 qui envisagerait de cr\u00e9er une entreprise ici, de la simplicit\u00e9 de la constitution d\u2019une soci\u00e9t\u00e9 aux raisons pour lesquelles les fondateurs devraient s\u2019installer \u00e0 proximit\u00e9 de l\u2019EPFL, o\u00f9, selon ses mots, on vient pour changer le monde. Et il conclut par des propositions concr\u00e8tes pour rendre la Suisse encore plus attractive pour les start-ups qui fa\u00e7onneront son avenir.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cet \u00e9pisode est disponible sur <a href=\"https:\/\/youtu.be\/xe4o_oTS1Pg\">YouTube<\/a> et <a href=\"https:\/\/open.spotify.com\/episode\/1nTPzn6zUZbmzQ1TWm720q?si=MDJ5a4dsRUW-_NhYjU4i9g\">Spotify<\/a>.<\/p>\n\n\n\n<figure class=\"wp-block-embed aligncenter is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"From EPFL to NASDAQ: How AI Is Changing Cancer Diagnosis (A Conversation with Jurgi Camblong)\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/xe4o_oTS1Pg?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Dans cet \u00e9pisode de Getting Serious, Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS, afin d\u2019explorer comment une start-up n\u00e9e \u00e0 l\u2019EPFL est devenue un leader mondial de la m\u00e9decine fond\u00e9e sur les donn\u00e9es, et pourquoi la Suisse lui a donn\u00e9 un avantage sur des concurrents issus de Harvard et de Stanford.<\/p>\n","protected":false},"author":6,"featured_media":40056,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[1263],"tags":[],"class_list":["post-40059","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-getting-serious-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)<\/title>\n<meta name=\"description\" content=\"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)\" \/>\n<meta property=\"og:description\" content=\"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T07:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/#\\\/schema\\\/person\\\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"De l\u2019EPFL au NASDAQ : comment l\u2019IA transforme le diagnostic du cancer (Entretien avec Jurgi Camblong)\",\"datePublished\":\"2026-10-27T07:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/\"},\"wordCount\":341,\"image\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ggba.swiss\\\/app\\\/uploads\\\/2026\\\/10\\\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png\",\"articleSection\":[\"Getting Serious\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/\",\"url\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/\",\"name\":\"Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ggba.swiss\\\/app\\\/uploads\\\/2026\\\/10\\\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png\",\"datePublished\":\"2026-10-27T07:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/#\\\/schema\\\/person\\\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ggba.swiss\\\/app\\\/uploads\\\/2026\\\/10\\\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png\",\"contentUrl\":\"https:\\\/\\\/ggba.swiss\\\/app\\\/uploads\\\/2026\\\/10\\\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png\",\"width\":1920,\"height\":1080,\"caption\":\"Dans cet \u00e9pisode de Getting Serious, Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS, afin d\u2019explorer comment une start-up n\u00e9e \u00e0 l\u2019EPFL est devenue un leader mondial de la m\u00e9decine fond\u00e9e sur les donn\u00e9es, et pourquoi la Suisse lui a donn\u00e9 un avantage sur des concurrents issus de Harvard et de Stanford.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ggba.swiss\\\/en\\\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ggba.swiss\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"De l\u2019EPFL au NASDAQ : comment l\u2019IA transforme le diagnostic du cancer (Entretien avec Jurgi Camblong)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/staging.ggba.swiss\\\/en\\\/#\\\/schema\\\/person\\\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\\\/\\\/ggba.swiss\\\/fr\\\/author\\\/pierre-yves-oehrli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)","description":"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/","og_locale":"fr_FR","og_type":"article","og_title":"Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)","og_description":"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.","og_url":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-10-27T07:00:00+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"De l\u2019EPFL au NASDAQ : comment l\u2019IA transforme le diagnostic du cancer (Entretien avec Jurgi Camblong)","datePublished":"2026-10-27T07:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/"},"wordCount":341,"image":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png","articleSection":["Getting Serious"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/","url":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/","name":"Comment l\u2019IA transforme le diagnostic du cancer (avec Jurgi Camblong)","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png","datePublished":"2026-10-27T07:00:00+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/10\/GGBa_202610_Getting-Serious_Jurgi-Camblong.png","width":1920,"height":1080,"caption":"Dans cet \u00e9pisode de Getting Serious, Woody se rend \u00e0 Rolle pour rencontrer Jurgi Camblong, cofondateur et pr\u00e9sident ex\u00e9cutif de SOPHiA GENETICS, afin d\u2019explorer comment une start-up n\u00e9e \u00e0 l\u2019EPFL est devenue un leader mondial de la m\u00e9decine fond\u00e9e sur les donn\u00e9es, et pourquoi la Suisse lui a donn\u00e9 un avantage sur des concurrents issus de Harvard et de Stanford."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/from-epfl-to-nasdaq-how-ai-is-changing-cancer-diagnosis-a-conversation-with-jurgi-camblong\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"De l\u2019EPFL au NASDAQ : comment l\u2019IA transforme le diagnostic du cancer (Entretien avec Jurgi Camblong)"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/40059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=40059"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/40059\/revisions"}],"predecessor-version":[{"id":40062,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/40059\/revisions\/40062"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/40056"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=40059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=40059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=40059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}